A structural study of Borna disease virus 1 (BoDV-1) has provided new insight into how the virus packages its RNA genome, offering information that may be relevant for laboratory detection and interpretation of test results.
BoDV-1 is a rare but clinically significant neurotropic virus linked to fatal encephalitis in humans. Unlike many other RNA viruses, it replicates in the nucleus and can persist in infected cells, which may complicate detection.
Using cryo–electron microscopy, researchers mapped the structure of the viral nucleoprotein (N) bound to RNA. This complex forms the core of the viral nucleocapsid – the structure that protects viral RNA and serves as the template for replication.
The study identified several forms of these complexes, including ring-shaped assemblies made up of multiple nucleoprotein units. Each unit binds approximately eight RNA nucleotides, a pattern that differs from related viruses. The interaction between the protein and RNA does not depend on the RNA sequence, but rather on the structure of the RNA backbone.
These findings help explain how viral RNA is organized and protected inside infected cells. This is relevant because the structure of the nucleocapsid can affect how easily viral RNA is extracted and detected in molecular assays, particularly in cases with low viral levels.
The researchers also identified specific amino acids required for RNA binding. When these sites were altered, the virus was no longer able to replicate RNA or form nuclear inclusion bodies – structures associated with viral replication. This confirms that the nucleoprotein–RNA interaction is essential for viral activity.
Another key finding is that nucleoprotein complexes can form before binding RNA. This suggests a stepwise assembly process, which differs from some other RNA viruses. Multiple structural states were observed, including both RNA-bound and RNA-free forms, indicating that the nucleoprotein is highly flexible.
This structural variability may help explain differences in viral behavior within cells and could influence how consistently viral material is detected in diagnostic samples.
The study addresses a longstanding gap in knowledge: BoDV-1 was the only human-infecting virus in its group without a defined nucleoprotein–RNA structure.
Additional studies will be needed to determine how these structural features affect detection in clinical samples and whether they contribute to variability in diagnostic sensitivity.
